1. Home
  2. Research
  3. Research Groups
  4. Psychiatric Diseases

Psychiatric Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos Á, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E.

    CIBERSAM: Ten years of collaborative translational research in mental disorders.

    REVISTA DE PSIQUIATRIA Y SALUD MENTAL . 12(1): 1-8. Number of citations: 44

    [doi:10.1016/j.rpsm.2018.10.001]

  • Menchón JM, Espadaler J, Tuson M, Saiz-Ruiz J, Bobes J, Vieta E, Álvarez E, Pérez V.

    Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial.

    JOURNAL OF NEURAL TRANSMISSION . 126(1): 95-99. Number of citations: 2

    [doi:10.1007/s00702-018-1879-z]

  • González-Álvarez S, Madoz-Gúrpide A, Parro-Torres C, Hernández-Huerta D, Ochoa Mangado E.

    Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV+ patients.

    Adicciones . 0(0): 916-916. Number of citations: 9

    [doi:10.20882/adicciones.916]

  • Boloc D, Gortat A, Cheng-Zhang JQ, García-Cerro S, Rodríguez N, Parellada M, Saiz-Ruiz J, Cuesta MJ, Gassó P, Lafuente A, Bernardo M, Mas S.

    Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

    TRANSLATIONAL PSYCHIATRY . 8(1): 276-276. Number of citations: 6

    [doi:10.1038/s41398-018-0330-4]

  • Ballesteros, Alejandro, Sanchez-Torres, Ana M., Lopez-Ilundain, Jose M., Cabrera, Bibiana, Lobo, Antonio, Gonzalez-Pinto, Ana M., Diaz-Caneja, Covadonga, Corripio, Iluminada, Vieta, Eduard, de la Serna, Elena, Bobes, Julio, Usall, Judith, Contreras, Fernando, Lorente-Omenaca, Ruth, Mezquida, Gisela, Bernardo, Miguel, Cuesta, Manuel J., PEPs Grp, Ibañez A.

    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    PSYCHOLOGICAL MEDICINE . 48(13): 2247-2256. Number of citations: 25

    [doi:10.1017/S0033291717003774]

  • Sánchez-Gutiérrez T, García-Portilla MP, Parellada M, Bobes J, Calvo A, Moreno-Izco L, González-Pinto A, Lobo A, de la Serna E, Cabrera B, Torrent C, Roldán L, Sanjuan J, Ibáñez Á, Sánchez-Torres AM, Corripio I, Bernardo M, Cuesta MJ, PEPs Group.

    Smoking does not impact social and non-social cognition in patients with first episode psychosis.

    SCHIZOPHRENIA RESEARCH . 199: 64-74. Number of citations: 12

    [doi:10.1016/j.schres.2018.03.025]

  • Sanchez-Moreno J, Bonnin CM, González-Pinto A, Amann BL, Solé B, Balanzá-Martinez V, Arango C, Jiménez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Martinez-Aran A, Torrent C, Vieta E, CIBERSAM Functional Remediation Group.

    Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables.

    ACTA PSYCHIATRICA SCANDINAVICA . 138(2): 145-154. Number of citations: 31

    [doi:10.1111/acps.12894]

  • Gassó P, Mas S, Bioque M, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Sarró S, Mané A, Sanjuan J, Llerena A, Lafuente A, Saiz-Ruiz J, Bernardo M, PEPs Group.

    Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.

    JOURNAL OF PSYCHOPHARMACOLOGY . 32(6): 702-710. Number of citations: 4

    [doi:10.1177/0269881118773026]

  • Alvarez-Mon MA, Asunsolo Del Barco A, Lahera G, Quintero J, Ferre F, Pereira-Sanchez V, Ortuño F, Alvarez-Mon M.

    Increasing Interest of Mass Communication Media and the General Public in the Distribution of Tweets About Mental Disorders: Observational Study.

    JOURNAL OF MEDICAL INTERNET RESEARCH . 20(5): . Number of citations: 19

    [doi:10.2196/jmir.9582]

  • Bioque M, García-Portilla MAP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Gutiérrez-Fraile M, Rodriguez-Jimenez R, Mezquida G, Llerena A, Saiz-Ruiz J, Bernardo M, PEPs GROUP.

    Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

    SCHIZOPHRENIA RESEARCH . 193: 188-196. Number of citations: 27

    [doi:10.1016/j.schres.2017.06.032]

  • Vieta E, Montes JM.

    A Review of Asenapine in the Treatment of Bipolar Disorder.

    CLINICAL DRUG INVESTIGATION . 38(2): 87-99. Number of citations: 15

    [doi:10.1007/s40261-017-0592-2]

  • López-Díaz Á, Lara I, Lahera G.

    Is the Prevalence of the Deficit Syndrome in Schizophrenia Higher than Estimated? Results of a Meta-Analysis.

    PSYCHIATRY INVESTIGATION . 15(1): 94-98. Number of citations: 9

    [doi:10.4306/pi.2018.15.1.94]

  • Brañas A, Barrigón ML, Lahera G, Canal-Rivero M, Ruiz-Veguilla M.

    Influence of depressive symptoms on distress related to positive psychotic-like experiences in women.

    PSYCHIATRY RESEARCH . 258: 469-475. Number of citations: 5

    [doi:10.1016/j.psychres.2017.08.094]

  • Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J, PEPs Group.

    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.

    JOURNAL OF CLINICAL PSYCHIATRY . 78(9): 1414-1422. Number of citations: 20

    [doi:10.4088/JCP.16m11122]

  • Bernardo M, Bioque M, Cabrera B, Lobo A, González-Pinto A, Pina L, Corripio I, Sanjuán J, Mané A, Castro-Fornieles J, Vieta E, Arango C, Mezquida G, Gassó P, Parellada M, Saiz-Ruiz J, Cuesta MJ, Mas S, PEPs GROUP.

    Modelling gene-environment interaction in first episodes of psychosis.

    SCHIZOPHRENIA RESEARCH . 189: 181-189. Number of citations: 30

    [doi:10.1016/j.schres.2017.01.058]

  • Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M, PEPs Group.

    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

    SCHIZOPHRENIA RESEARCH . 189: 84-90. Number of citations: 24

    [doi:10.1016/j.schres.2017.01.047]

  • Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J, Vieta E.

    Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(10): 959-969. Number of citations: 9

    [doi:10.1016/j.euroneuro.2017.08.429]

  • Lahera G, Ruiz A, Brañas A, Vicens M, Orozco A.

    Reaction time, processing speed and sustained attention in schizophrenia: impact on social functioning.

    REVISTA DE PSIQUIATRIA Y SALUD MENTAL . 10(4): 197-205. Number of citations: 20

    [doi:10.1016/j.rpsm.2017.04.001]